BACKGROUND: GMZ2 is a recombinant malaria vaccine inducing immune responses against Plasmodium falciparum (Pf) merozoite surface protein-3 and glutamate-rich protein. We used standardized controlled human malaria infection (CHMI) to assess the efficacy of this asexual blood-stage vaccine. METHODS: We vaccinated 50 healthy, adult volunteers with lifelong exposure to Pf 3 times, at 4-week intervals, with 30 or 100 µg GMZ2 formulated in CAF01, a liposome-based adjuvant; 100 µg GMZ2, formulated in Alhydrogel; or a control vaccine (Verorab). Approximately 13 weeks after the last vaccination, 35/50 volunteers underwent CHMI by direct venous inoculation of 3200 Pf sporozoites (Sanaria® PfSPZ Challenge). RESULTS: Adverse events were similarly distributed between GMZ2 and control vaccinees. Baseline-corrected anti-GMZ2 antibody concentrations 4 weeks after the last vaccination were higher in all 3 GMZ2-vaccinated arms, compared to the control group. All GMZ2 formulations induced similar antibody levels. CHMI resulted in 29/34 (85%) volunteers with Pf parasitemia and 15/34 (44%) with malaria (parasitemia and symptoms). The proportion of participants with malaria (2/5 control, 6/10 GMZ2-Alhydrogel, 2/8 30 µg GMZ2-CAF01, and 5/11 100 µg GMZ2-CAF01) and the time it took them to develop malaria were similar in all groups. Baseline, vaccine-specific antibody concentrations were associated with protection against malaria. CONCLUSIONS: GMZ2 is well tolerated and immunogenic in lifelong-Pf-exposed adults from Gabon, with similar antibody responses regardless of formulation. CHMI showed no protective effect of prior vaccination with GMZ2, although baseline, vaccine-specific antibody concentrations were associated with protection. CHMI with the PfSPZ Challenge is a potent new tool to validate asexual, blood-stage malaria vaccines in Africa. CLINICAL TRIALS REGISTRATION: Pan-African Clinical Trials: PACTR201503001038304.
BACKGROUND:GMZ2 is a recombinant malaria vaccine inducing immune responses against Plasmodium falciparum (Pf) merozoite surface protein-3 and glutamate-rich protein. We used standardized controlled humanmalaria infection (CHMI) to assess the efficacy of this asexual blood-stage vaccine. METHODS: We vaccinated 50 healthy, adult volunteers with lifelong exposure to Pf 3 times, at 4-week intervals, with 30 or 100 µg GMZ2 formulated in CAF01, a liposome-based adjuvant; 100 µg GMZ2, formulated in Alhydrogel; or a control vaccine (Verorab). Approximately 13 weeks after the last vaccination, 35/50 volunteers underwent CHMI by direct venous inoculation of 3200 Pf sporozoites (Sanaria® PfSPZ Challenge). RESULTS: Adverse events were similarly distributed between GMZ2 and control vaccinees. Baseline-corrected anti-GMZ2 antibody concentrations 4 weeks after the last vaccination were higher in all 3 GMZ2-vaccinated arms, compared to the control group. All GMZ2 formulations induced similar antibody levels. CHMI resulted in 29/34 (85%) volunteers with Pfparasitemia and 15/34 (44%) with malaria (parasitemia and symptoms). The proportion of participants with malaria (2/5 control, 6/10 GMZ2-Alhydrogel, 2/8 30 µg GMZ2-CAF01, and 5/11 100 µg GMZ2-CAF01) and the time it took them to develop malaria were similar in all groups. Baseline, vaccine-specific antibody concentrations were associated with protection against malaria. CONCLUSIONS:GMZ2 is well tolerated and immunogenic in lifelong-Pf-exposed adults from Gabon, with similar antibody responses regardless of formulation. CHMI showed no protective effect of prior vaccination with GMZ2, although baseline, vaccine-specific antibody concentrations were associated with protection. CHMI with the PfSPZ Challenge is a potent new tool to validate asexual, blood-stage malaria vaccines in Africa. CLINICAL TRIALS REGISTRATION: Pan-African Clinical Trials: PACTR201503001038304.
Authors: Mirjam Groger; Luzia Veletzky; Albert Lalremruata; Chiara Cattaneo; Johannes Mischlinger; Rella Zoleko-Manego; Lilian Endamne; Anna Klicpera; Johanna Kim; The Nguyen; Lena Flohr; Jonathan Remppis; Pierre-Blaise Matsiegui; Ayôla A Adegnika; Selidji T Agnandji; Peter G Kremsner; Benjamin Mordmüller; Ghyslain Mombo-Ngoma; Michael Ramharter Journal: Antimicrob Agents Chemother Date: 2018-02-23 Impact factor: 5.191
Authors: Mahamadou A Thera; Ogobara K Doumbo; Drissa Coulibaly; Matthew B Laurens; Amed Ouattara; Abdoulaye K Kone; Ando B Guindo; Karim Traore; Idrissa Traore; Bourema Kouriba; Dapa A Diallo; Issa Diarra; Modibo Daou; Amagana Dolo; Youssouf Tolo; Mahamadou S Sissoko; Amadou Niangaly; Mady Sissoko; Shannon Takala-Harrison; Kirsten E Lyke; Yukun Wu; William C Blackwelder; Olivier Godeaux; Johan Vekemans; Marie-Claude Dubois; W Ripley Ballou; Joe Cohen; Darby Thompson; Tina Dube; Lorraine Soisson; Carter L Diggs; Brent House; David E Lanar; Sheetij Dutta; D Gray Heppner; Christopher V Plowe Journal: N Engl J Med Date: 2011-09-15 Impact factor: 91.245
Authors: Kirsten E Lyke; Andrew S Ishizuka; Andrea A Berry; Sumana Chakravarty; Adam DeZure; Mary E Enama; Eric R James; Peter F Billingsley; Anusha Gunasekera; Anita Manoj; Minglin Li; Adam J Ruben; Tao Li; Abraham G Eappen; Richard E Stafford; Natasha Kc; Tooba Murshedkar; Floreliz H Mendoza; Ingelise J Gordon; Kathryn L Zephir; LaSonji A Holman; Sarah H Plummer; Cynthia S Hendel; Laura Novik; Pamela J M Costner; Jamie G Saunders; Nina M Berkowitz; Barbara J Flynn; Martha C Nason; Lindsay S Garver; Matthew B Laurens; Christopher V Plowe; Thomas L Richie; Barney S Graham; Mario Roederer; B Kim Lee Sim; Julie E Ledgerwood; Stephen L Hoffman; Robert A Seder Journal: Proc Natl Acad Sci U S A Date: 2017-02-21 Impact factor: 11.205
Authors: David J Pombo; Gregor Lawrence; Chakrit Hirunpetcharat; Christine Rzepczyk; Michelle Bryden; Nicole Cloonan; Karen Anderson; Yuvadee Mahakunkijcharoen; Laura B Martin; Danny Wilson; Salenna Elliott; Suzanne Elliott; Damon P Eisen; J Brice Weinberg; Allan Saul; Michael F Good Journal: Lancet Date: 2002-08-24 Impact factor: 79.321
Authors: Robert A Seder; Lee-Jah Chang; Mary E Enama; Kathryn L Zephir; Uzma N Sarwar; Ingelise J Gordon; LaSonji A Holman; Eric R James; Peter F Billingsley; Anusha Gunasekera; Adam Richman; Sumana Chakravarty; Anita Manoj; Soundarapandian Velmurugan; MingLin Li; Adam J Ruben; Tao Li; Abraham G Eappen; Richard E Stafford; Sarah H Plummer; Cynthia S Hendel; Laura Novik; Pamela J M Costner; Floreliz H Mendoza; Jamie G Saunders; Martha C Nason; Jason H Richardson; Jittawadee Murphy; Silas A Davidson; Thomas L Richie; Martha Sedegah; Awalludin Sutamihardja; Gary A Fahle; Kirsten E Lyke; Matthew B Laurens; Mario Roederer; Kavita Tewari; Judith E Epstein; B Kim Lee Sim; Julie E Ledgerwood; Barney S Graham; Stephen L Hoffman Journal: Science Date: 2013-08-08 Impact factor: 47.728
Authors: Benjamin Mordmüller; Güzin Surat; Heimo Lagler; Sumana Chakravarty; Andrew S Ishizuka; Albert Lalremruata; Markus Gmeiner; Joseph J Campo; Meral Esen; Adam J Ruben; Jana Held; Carlos Lamsfus Calle; Juliana B Mengue; Tamirat Gebru; Javier Ibáñez; Mihály Sulyok; Eric R James; Peter F Billingsley; K C Natasha; Anita Manoj; Tooba Murshedkar; Anusha Gunasekera; Abraham G Eappen; Tao Li; Richard E Stafford; Minglin Li; Phil L Felgner; Robert A Seder; Thomas L Richie; B Kim Lee Sim; Stephen L Hoffman; Peter G Kremsner Journal: Nature Date: 2017-02-15 Impact factor: 49.962
Authors: Jona Walk; Remko Schats; Marijke C C Langenberg; Isaie J Reuling; Karina Teelen; Meta Roestenberg; Cornelus C Hermsen; Leo G Visser; Robert W Sauerwein Journal: Malar J Date: 2016-08-05 Impact factor: 2.979
Authors: Victorine A Mensah; Aly Gueye; Magatte Ndiaye; Nick J Edwards; Danny Wright; Nicholas A Anagnostou; Massamba Syll; Amy Ndaw; Annie Abiola; Carly Bliss; Jules-François Gomis; Ines Petersen; Caroline Ogwang; Tandakha Dieye; Nicola K Viebig; Alison M Lawrie; Rachel Roberts; Alfredo Nicosia; Babacar Faye; Oumar Gaye; Odile Leroy; Egeruan B Imoukhuede; Katie J Ewer; Philip Bejon; Adrian V S Hill; Badara Cisse Journal: PLoS One Date: 2016-12-15 Impact factor: 3.240
Authors: Albert Lalremruata; The Trong Nguyen; Matthew B B McCall; Ghyslain Mombo-Ngoma; Selidji T Agnandji; Ayôla A Adegnika; Bertrand Lell; Michael Ramharter; Stephen L Hoffman; Peter G Kremsner; Benjamin Mordmüller Journal: J Clin Microbiol Date: 2020-04-23 Impact factor: 5.948
Authors: Odilon Nouatin; Ulysse Ateba Ngoa; Javier Ibáñez; Jean Claude Dejon-Agobe; Benjamin Mordmüller; Jean Ronald Edoa; Fabrice Mougeni; Sina Brückner; Aurore Bouyoukou Hounkpatin; Meral Esen; Michael Theisen; Kabirou Moutairou; Stephen L Hoffman; Saadou Issifou; Adrian J F Luty; Marguerite M Loembe; Selidji Todagbé Agnandji; Bertrand Lell; Peter G Kremsner; Ayôla Akim Adegnika Journal: Vaccine Date: 2020-05-05 Impact factor: 3.641
Authors: Matthew B Laurens; Andrea A Berry; Mark A Travassos; Kathy Strauss; Matthew Adams; Biraj Shrestha; Tao Li; Abraham Eappen; Anita Manoj; Yonas Abebe; Tooba Murshedkar; Anusha Gunasekera; Thomas L Richie; Kirsten E Lyke; Christopher V Plowe; Jessie K Kennedy; Gail E Potter; Gregory A Deye; B K L Sim; Stephen L Hoffman Journal: J Infect Dis Date: 2019-11-06 Impact factor: 5.226
Authors: Robert K M Choy; A Louis Bourgeois; Christian F Ockenhouse; Richard I Walker; Rebecca L Sheets; Jorge Flores Journal: Clin Microbiol Rev Date: 2022-07-06 Impact factor: 50.129
Authors: Angela M Minassian; Sarah E Silk; Jordan R Barrett; Carolyn M Nielsen; Kazutoyo Miura; Ababacar Diouf; Carolin Loos; Jonathan K Fallon; Ashlin R Michell; Michael T White; Nick J Edwards; Ian D Poulton; Celia H Mitton; Ruth O Payne; Michael Marks; Hector Maxwell-Scott; Antonio Querol-Rubiera; Karen Bisnauthsing; Rahul Batra; Tatiana Ogrina; Nathan J Brendish; Yrene Themistocleous; Thomas A Rawlinson; Katherine J Ellis; Doris Quinkert; Megan Baker; Raquel Lopez Ramon; Fernando Ramos Lopez; Lea Barfod; Pedro M Folegatti; Daniel Silman; Mehreen Datoo; Iona J Taylor; Jing Jin; David Pulido; Alexander D Douglas; Willem A de Jongh; Robert Smith; Eleanor Berrie; Amy R Noe; Carter L Diggs; Lorraine A Soisson; Rebecca Ashfield; Saul N Faust; Anna L Goodman; Alison M Lawrie; Fay L Nugent; Galit Alter; Carole A Long; Simon J Draper Journal: Med (N Y) Date: 2021-06-11